Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideDGXQuest Diagnostics
FinDog View：Neutral
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | DGX | JNJ |
|---|
| Close | 247.08 | 267.28 |
| Market Cap | $27.3B | $644B |
| 1M | +4.91% | +1.87% |
| P/E (TTM) | 25.7 | 30.6 |
| Forward P/E | 20.1 | 20.7 |
| P/E 5-Yr Percentile | 97 | 90 |
| P/S | 2.4 | 6.6 |
| P/B | 3.6 | 7.6 |
| Dividend Yield | 2.10% | 3.12% |
| Latest Quarter Revenue | $3.0B | $25.3B |
| Revenue YoY | +10.2% | +6.6% |
| Gross Margin | 33.7% | 68.2% |
| Latest Quarter EPS | 2.84 | 2.27 |
| Avg Post-Earnings Move | ±1.7% | ±0.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.98% | 1.25% |
| 90-Day Net Insider Buying | −$8.3M | −$67.8M |
DGX · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
